North America Clinical Trial Supply & Logistics Market to Grow with a CAGR of 6.81% through 2029
Rise in biopharmaceutical research advancements is expected
to drive the North America Clinical Trial Supply & Logistics Market growth
in the forecast period, 2025-2029.
According to TechSci Research report, “Clinical
Trial Supply & Logistics Market – North America Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the North
America Clinical Trial Supply & Logistics Market stood at USD 1.2 billion in
2023 and is anticipated to grow with a CAGR of 6.81% in the forecast period,
2025-2029. One of the primary drivers fueling the growth of the North America
Clinical Trial Supply & Logistics market is the escalating number of
clinical trials conducted in the region. With the United States and Canada at
the forefront of pharmaceutical research and development, a multitude of
companies are engaging in clinical trials to bring new drugs and therapies to
market. This surge in clinical trial activity directly translates into a
heightened demand for reliable and streamlined supply chain services,
encompassing packaging, labeling, storage, and distribution of investigational
products. The continuous evolution of biopharmaceutical research is another
pivotal factor propelling the demand for specialized clinical trial supply and
logistics services. As the industry witnesses groundbreaking developments in
areas like genomics, precision medicine, and biologics, the nature of clinical
trials becomes more complex. The need for customized supply chain solutions,
including temperature-controlled logistics for biologics and personalized
medicines, is on the rise. This trend is reshaping the landscape of clinical
trial logistics, with a focus on ensuring the integrity and stability of
sensitive investigational products.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "North America Clinical Trial Supply & Logistics Market”
The North America Clinical Trial Supply &
Logistics Market is segmented into Service, Therapeutic Area, Phase, Regional
Distribution, And Company.
Based on the Service, logistics & distribution
emerged as the dominant segment in the North America market for North America
Clinical Trial Supply & Logistics Market in 2023. Many
investigational drugs and biological samples used in clinical trials are
temperature sensitive. Logistics providers specializing in clinical trials must
have the capability to handle and transport these products within specified
temperature ranges. This includes the use of temperature-controlled packaging,
monitoring systems, and transportation modes to prevent any degradation of the
investigational products. The
pharmaceutical and biotechnology industries are increasingly conducting
clinical trials on a global scale to ensure diverse patient populations and
efficient recruitment. This globalization necessitates a robust logistics and
distribution network to seamlessly transport investigational drugs, medical
devices, and other trial materials across borders while adhering to varying
regulatory requirements. Clinical trials involve a complex and multifaceted
supply chain, from the manufacturing of investigational products to their
distribution to numerous trial sites.
Based on the Therapeutic Area, oncology emerged as
the dominant segment in the North America market for North America Clinical
Trial Supply & Logistics Market in 2023. Oncology trials are known for
their complexity, involving multiple study arms, biomarker-driven approaches,
and adaptive trial designs. The intricate nature of these trials requires
sophisticated logistics management to handle the diverse and specific needs of
investigational products. From temperature-sensitive biologics to complex trial
designs, the logistics challenges in oncology trials contribute significantly
to the demand for specialized supply chain services. Collaborative efforts and
international partnerships are common in oncology research. Clinical trials
often involve collaboration between pharmaceutical companies, research
institutions, and healthcare organizations across different countries. This
globalized approach to oncology research adds an extra layer of complexity to
the supply chain, requiring expertise in managing global logistics and
navigating diverse regulatory environments.
Based on the Phase, Phase III emerged as the dominant
segment in the North America market for North America Clinical Trial Supply
& Logistics Market in 2023. Phase III trials are characterized by their
large scale, involving a substantial number of participants across multiple
sites and often conducted on an international scale. The complexity of these
trials, which may include diverse patient populations, various geographic
locations, and rigorous study designs, necessitates sophisticated supply chain
and logistics solutions. The sheer scale and intricacy of Phase III trials
amplify the demand for efficient and reliable clinical trial supply services.
Many Phase
III trials involve global collaboration, with research sites spanning multiple
countries. The coordination and management of clinical trial supplies across
diverse regions, each with its regulatory requirements and logistical
challenges, further amplify the demand for specialized supply chain solutions.
The ability to seamlessly navigate global logistics complexities becomes
essential during Phase III trials, contributing to the high demand for supply
and logistics services.
United States emerged as the dominant player in the
North America Clinical Trial Supply & Logistics Market in 2023, holding the
largest market share. North America’s robust healthcare
infrastructure and advanced logistics networks established it as an ideal
center for clinical trial operations. The nation's regulatory framework,
characterized by stringent yet manageable protocols, inspired trust among
stakeholders and created a conducive environment for trial activities. The US possessed abundant expertise in
pharmaceuticals and biotechnology, attracting international players eager to
leverage its resources. This combination of strengths gave the US a competitive
advantage, streamlining supply chain and logistics management essential for
successful clinical trials. Consequently, the country emerged as the leading
contender, setting a high standard for excellence in the North American
clinical trial sector..
Major companies operating in North America Clinical
Trial Supply & Logistics Market are:
- Thermo Fisher Scientific Inc.
- Catalent, Inc.
- Parexel International (MA) Corporation
- Almac Group Inc
- Marken LLC
- Piramal Pharma Solutions
- Evoke Health LLC
- DHL International Ltd
- FedEx Corporation
- Packaging Coordinators Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The North
America Clinical Trial Supply & Logistics Market is poised for substantial
growth in the coming years. With an increasing emphasis on personalized
medicine, innovative therapies, and the globalization of clinical trials, the
demand for specialized supply chain solutions is expected to surge. The
region's robust pharmaceutical and biotechnology industry, particularly in the
United States, contributes significantly to the market's growth. The evolution toward decentralized trials, advancements in biopharmaceuticals,
and the integration of cutting-edge technologies in logistics are anticipated
to fuel expansion. As clinical trials become more complex and diverse, the
North America Clinical Trial Supply & Logistics market is positioned to
play a pivotal role in supporting the seamless movement of investigational
products, ultimately contributing to advancements in healthcare and the
development of novel therapeutic solutions.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“North America Clinical Trial Supply &
Logistics Market Segmented By Service (Logistics & distribution, Storage
& retention, Packaging, labeling, and blinding, Manufacturing, Comparator
sourcing, other services), By Therapeutic Area (Oncology, Cardiovascular
Diseases, Respiratory Diseases, CNS And Mental Disorders, Others), By Phase
(Phase I, Phase II, Phase III, Phase IV) Region and Competition, Opportunity,
and Forecast, 2019-2029”, has evaluated the future growth potential of North
America Clinical Trial Supply & Logistics Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in North America Clinical Trial Supply & Logistics Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
[email protected]
Website:
www.techsciresearch.com